HiFiBiO CEO on the Keys to Global Biotech Success
HiFiBiO Therapeutics cofounder, CEO and CSO Dr Liang Schweizer fits the profile of a Chinese biotech CEO to a T: advanced degrees in different…
Tagged with France
Liang Schweizer – CEO & CSO, HiFiBiO Therapeutics
Dr Liang Schweizer introduces immunotherapy-focused biotech HiFiBiO Therapeutics, the main advantages of the company’s unique single-cell technology…
France: ‘Humiliation’ & the Sanofi-Pfizer Vaccine Deal;…
The latest from French pharma where Sanofi has inked a deal to produce 125 million doses of Pfizer’s COVID-19 vaccine as it faces delays with its…
Ipsen CEO David Loew on M&A, Rare Disease Expansion, Niche…
In a wide-ranging and exclusive interview with PharmaBoardroom, Ipsen CEO David Loew looks back on an atypical first 100 days at the helm of the…
France: Mid-2021 for Sanofi COVID-19 Vaccine; 1 Million Domestic…
A roundup of the latest stories from French pharma, including the progress of Sanofi’s COVID-19 vaccine, how Ipsen has managed to achieve sales…
French Pharma News Roundup August 2020
A roundup of some of the latest from French pharma, including Sanofi’s bumper Prinicipia deal, how Unither’s new Chinese acquisition catapults it…
Sanofi Buys Principia for USD 3.7 Billion as Part of Specialty…
Sanofi has agreed a deal to buy out its partner, US biotech company Principia Biopharma for USD 3.7 billion in cash, giving the French giant full…
Sanofi Pasteur Appoints Thomas Triomphe as New Executive Vice…
With former head David Loew moving to the CEO position at Ipsen, Sanofi appointed French national Thomas Triomphe as the new head of its vaccines…
Sanofi Makes USD 679 Million Investment in French Vaccine…
French pharma giant Sanofi is pivoting its focus to invest more heavily in vaccines with a plan to invest USD 679 million in vaccine manufacturing…
Skyepharma’s David Lescuyer on Manufacturing & Supply…
David Lescuyer, managing director of fully integrated French CDMO Skyepharma, outlines how the COVID-19 crisis could usher in a new era for the…
New CEO for Ipsen as David Loew Makes Switch From Sanofi Pasteur
David Loew, formerly executive vice president of Sanofi Pasteur, Sanofi's vaccines division, was appointed CEO of fellow French firm Ipsen on the 28th…
France & Germany: A New European Approach to Health Crises
Emmanuel Macron and Angela Merkel recently put their heads together to come up with a health strategy that would ensure greater European access to…
